摘要
近年来,甲状腺癌的发病率逐年增高,其治疗方案以及预后效果成为关注的热点。美国甲状腺协会于1996年第一次发布《成人甲状腺结节与分化型甲状腺癌治疗指南》,继2009年修订后,2015年美国甲状腺协会对其再次更新,并在疾病风险分层、治疗手段的不同指征、治疗剂量及随访中血清和影像学等方面进行更新和补充修订。
In recent years, the prevalence of thyroid cancer increased, the related prognostic and treatment effect are becoming hot spots of attention. In 1996, the American Thyroid Association（ATA） published treatment guidelines for patients with thyroid nodules and differentiated thyroid cancer, then revised in 2009, the American Thyroid Association update it again in 2015. They put forward some new ideas and complements as follows： risk stratification system, treatment of different identifications, therapeutic dose and follow-up serum Tg and imagings, such as CT/MR.
出处
《肿瘤学杂志》
CAS
2016年第11期875-879,共5页
Journal of Chinese Oncology
基金
国家重大科学仪器设备开发专项(2011YQ03011409)
十二五国家支撑项目基金(2014BAA03B03)
关键词
甲状腺肿瘤
131I治疗
疾病风险分层
分子标志物
thyroid neoplasms
131I radioactive therapy
risk stratification system
molecular marker
